The 2021 Aspen Lung Conference has the following Specific Aims / Objectives
Local/Regional/National/International Physicians/Clinicians (adult and pediatric)/Research Physician-Scientists in Pulmonary Sciences, Critical Care and Sleep Medicine/Primary Care Physicians/General Medicine Physicians/Public Health.
The Acute Respiratory Distress Syndrome (ARDS) represents a common syndrome arising from numerous, heterogeneous, and often-independent disease processes. Accordingly, a single potential pharmacologic treatment for ARDS, if uniformly applied to all patients regardless of underlying disease pathophysiology, would likely fail to consistently improve patient outcomes. For clinical studies to overcome this obstacle, a new appreciation of ARDS mechanistic and phenotypic heterogeneity is required, enabling future precision medicine approaches to the recognition and treatment of lung injury.
The 2021 Thomas L. Petty Aspen Lung Conference, entitled ARDS in the 21st Century: New Insights Into Clinical and Mechanistic Heterogeneity, will integrate cutting edge basic, translational, and clinical research to address the impact of ARDS heterogeneity, with a focus on (1) understanding the presence and therapeutic significance of ARDS mechanistic and phenotypic subtypes, (2) exploring multi-cellular and multi-systemic mechanisms responsible for this heterogeneity, and (3) determining how to best account for disease heterogeneity during clinical trial design and outcome assessment.
This Conference will provide an international forum bringing together leading basic, translational, and clinical ARDS researchers while welcoming research trainees in pulmonology and critical care medicine, with the goal of identifying shared interests that will lead to more productive research and more effective personalized therapies. Finally, the varied scientific themes and therapeutic strategies emerging during the conference will be reconciled in a concluding Conference Summary presented by Dr. Thomas Martin (University of Washington). Three Thomas L. Petty Fellow Travel Awards will be awarded in the amount of $1,000/award to help defray the costs for female and under-represented minority fellows to present an abstract
In summary, the conference distinguishes itself from other conference in this field by serving as a “think tank” to actively discuss the current state of the field and identify the future directions for basic, translational and clinical research in ARDS.
For more information, contact: Eric Schmidt, M.D., c/o Jeanne Cleary, Thomas L. Petty Aspen Lung Conference, PO Box 1622, Parker, CO 80134 Phone: (303) 358-2797. E-Mail: Jeanne.Cleary@ucdenver.edu or visit our website at www.aspenlungconference.org.
THOMAS L. PETTY ASPEN LUNG CONFERENCE
63rd Annual Meeting
June 9 - June 12, 2021
“ARDS in the 21st Century: New Insights into Clinical
and Mechanistic Heterogeneity”
Eric P. Schmidt, M.D., Chair
Lorraine B. Ware, M.D., Chair
Rachel L. Zemans, M.D., Chair
“ARDS from the 20th to 21st Century”
Michael A. Matthay, M.D.
San Francisco, California
“ARDS Subphenotypes and Impact on Treatment Response”
Carolyn S. Calfee, M.D.
San Francisco, California
“Genetic Heterogeneity of ARDS”
Nuala Meyer, M.D., M.S. (MSTR)
“WNT Signaling Niches in Alveolar Epithelial Repair”
Tushar Desai, M.D.
“Regeneration of the Alveolar Epithelium After Acute Lung Injury”
Rachel L. Zemans, M.D.
Ann Arbor, Michigan
“Lung Endothelial Modulation of Brain Dysfunction After Pulmonary Infection”
Troy Stevens, Ph.D.
“The Angiopoietins and Tie-2 in Sepsis and ARDS”
Samir Parikh, M.D.
“Clinical Trial Design in the Age of Heterogeneity”
B. Taylor Thompson, M.D.
“Novel Computational Approaches to Translate Patient
Heterogeneity into Mechanistic Insights”
Lisa Bastarache, M.S.
“Neutrophil-Platelet Interactions in ARDS”
Mark R. Looney, M.D.
San Francisco, California
“Macrophage Dynamics and Functional Heterogeneity in Lung Injury and Repair”
Suzanne V. Herold, M.D., Ph.D.
“The Multiple Phenotypes of Chronic Critical Illness”
Catherine “Terri” Hough, M.D., M.S.
Thomas R. Martin, M.D.
We look forward to your participation in the Thomas L. Petty Aspen Lung Conference, 63rd Annual Meeting and to a combination of outstanding science and great fun. We hope that you and your colleagues are able to join us.
Americans with Disabilities Act Statement: Please indicate if you have any need for auxiliary aids or special assistance services.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Colorado School
of Medicine and the Aspen Lung Conference. The University of Colorado School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
ARDS in the 21st Century: New Insights into Clinical and Mechanistic Heterogeneity
June 10-13, 2021
Lung and the Immune System: Disease Pathogenesis, Treatment, and Complications with Immunotherapy